Abstract:Background The absent in melanoma 2 (AIM2) inflammasome is a multi-protein platform that recognizes aberrant cytoplasmic double-stranded DNA(dsDNA) and induces cytokine maturation, release, and pyroptosis. Some studies found that the AIM2 inflammasome was a double-edged sword in many cancers. However, there have been fewer studies on AIM2 inflammasomes in pan-cancer. Methods Gene expression was analyzed using The Cancer Genome Atlas (TCGA) database and The Genotype-Tissue Expression (GTEx) database. Immunohistochemistry (IHC) was used to validate the expression of the AIM2. We used the survival curve to explore the prognostic significance of the AIM2 inflammasomes in pan-cancer. Mutations and methylation of AIM2 inflammasome-related genes (AIM2i-RGs) were also comprehensively analyzed. Single sample gene set enrichment analysis was used to calculate the AIM2 inflammasomes score and explore the correlation of the AIM2 inflammasomes score with immune-related genes and immune infiltrations. The function of AIM2 inflammasomes in pan-cancer was analyzed at the single-cell level. Single-cell transcriptome sequencing (scRNA-seq) data was used to assess the activation state of the AIM2 inflammasomes in the tumor microenvironment. Results We found that AIM2i-RGs were aberrantly expressed in tumors and were strongly associated with prognosis. In pan-cancer, the expression of AIM2i-RGs was positively associated with copy number variation and negatively associated with methylation. In AIM2i-RGs, missense mutations were the predominant type of single nucleotide polymorphism. Moreover, we found that the drugs dimethyloxallyl glycine (DMOG) and Z-LNle-CHO may be sensitive to the AIM2 inflammasomes. The AIM2 inflammasomes score was significantly and positively correlated with the tumor immunity score and the stroma score. In most tumors, the AIM2 inflammasomes score was significantly and positively correlated with CD8+ T cell abundance in the tumor microenvironment. Additionally, the AIM2 inflammasomes score was significantly correlated with immune checkpoint genes in pan-cancer as well as immune checkpoint therapy-related markers including tumor mutational burden (TMB), microsatellite instability(MSI), and tumor immune dysfunction and exclusion(TIDE). scRNA-seq analysis suggested that AIM2 inflammasomes differ significantly among different cells in the tumor microenvironment. IHC confirmed low expression of AIM2 in colorectal cancer. Discussion AIM2 inflammasomes may be a new target for future tumor therapy It is likely involved in tumor development, and its high expression may serve as a predictor of tumor immunotherapy efficacy.

Expression and Clinical Significance of Absent in Melanoma 2 in Pancreatic Cancer

Expression and Clinical Significance of Absent in Melanoma 2 in Colorectal Cancer.

Expression of absent in melanoma 2 in the liver and correlation with the degrees of liver damage in patients with chronic hepatitis B

Expression of AIM2 and serum CEA level in patients with colorectal cancer and its clinical significance

Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients

The Expression and Clinical Significance of P21~(WAF1) MDM-2 in Pancreatic Carcinoma

Expression and Significance of P53 and Bcl-2 Protein Pancreatic Adenocarcinoma

Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.

AIM2 is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response of Clear Cell Renal Cell Carcinoma

The role of AIM2 in human hepatocellular carcinoma and its clinical significance

Expression and correlations of S-phase kinase associated protein 2 and P27 protein in pancreatic cancer tissues: an analyses of 51 cases

Expressions of P53 and Bcl-2 in Pancreatic Carcinoma and Its Clinical Significance

Clinical Significance of XAF1 Expression in Pancreatic Cancer and Its Relationship with Prognosis

The expressions and significance of MMP-2 and TIMP-2 in human pancreatic carcinoma

Expression and its clinical significance of CD9 protein in pancreatic cancer

Expression and significance of EphA2 and E-cadherin in pancreatic carcinoma

Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation

Expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme in pancreatic cancer and their relationship

Clinical Significance of Expression of Olfactory Receptor Family 2 Subfamily W Member 3 in Human Pancreatic Cancer

The Expression and Clinical Significance of Matrix Metalloproteinase-2 in Human Pancreatic Carcinoma.